Related Experiment Video
Updated: Aug 13, 2025

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.5K
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper
Dale Jobson1,2, Benjamin Roffey2, Renee Best3
1Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia.
BMJ Open
|January 23, 2023
Summary
The Australian Melanoma Clinical Outcomes Registry (MelCOR) will collect data on cutaneous melanoma care to identify variations and provide feedback. This aims to improve patient outcomes by benchmarking clinician performance across Australia.
Area of Science:
- Oncology
- Public Health
- Health Services Research
Background:
- Australia has the highest global incidence of melanoma.
- Care for melanoma patients varies significantly among clinicians.
- Clinical quality registries are essential for identifying and addressing variations in care.
Purpose of the Study:
- To establish the Australian Melanoma Clinical Outcomes Registry (MelCOR).
- To collect population-wide, clinical-level data for early cutaneous melanoma management.
- To provide anonymised, benchmarked feedback to healthcare providers to improve patient outcomes.
Main Methods:
- A modified Delphi process will identify key clinical quality indicators.
- MelCOR will prospectively collect data from patients aged over 18 in Victoria and Queensland with histopathologically confirmed melanoma.
- A two-stage recruitment process involves clinician opt-out and patient opt-in for data collection and patient-reported outcomes.
Main Results:
- The pilot phase will establish feasibility for data collection and feedback mechanisms.
- Data collected will focus on key quality indicators, with future expansion planned.
- Aggregated data will enable comparative feedback to institutions and clinicians.
Conclusions:
- MelCOR aims to standardize and improve the quality of melanoma care across Australia.
- Benchmarked feedback will support continuous quality improvement in melanoma management.
- The registry will provide annual reports to stakeholders and the public.
Related Concept Videos
Skin Cancer
4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Cancer Survival Analysis
410
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
410
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

